MediPharm Labs Corp. (TSX:LABS)

MediPharm Labs Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.87	10.81	11.69	17.98	24.15	34.11
Cash & Short-Term Investments	9.87	10.81	11.69	17.98	24.15	34.11
Cash Growth	16.85%	-7.56%	-34.99%	-25.53%	-29.21%	71.30%
Accounts Receivable	6.53	7.53	7.51	5.87	12.88	16.92
Inventory	8.47	8.02	8.71	9.9	7.78	10.98
Other Current Assets	0.86	1.11	5.17	2.89	2.55	3.54
Total Current Assets	25.73	27.47	33.08	36.63	93.86	65.55
Net Property, Plant & Equipment	17.26	17.6	19.16	25.27	18.11	25.89
Other Intangible Assets	0.63	0.68	0.85	1.03	0.04	0.04
Other Long-Term Assets	-	-	0.64	1	-	0.88
Total Assets	43.62	45.74	53.73	63.94	65.5	92.36

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.68	9.2	7.86	6.75	7.12	6.21
Accrued Expenses	0.82	0.52	2.3	1.89	1.74	2.55
Short-Term Debt	0.02	0.2	0.34	2.23	0.6	0.11
Unearned Revenue	-	-	-	-	-	0
Total Current Liabilities	8.52	9.93	10.5	10.86	9.46	8.88
Long-Term Debt	-	-	0.05	0.07	0.03	0.1
Other Long-Term Liabilities	-	-	-	-	-	0.24
Total Long-Term Liabilities	-	-	0.05	0.07	0.03	0.34
Total Liabilities	8.52	9.93	10.55	10.93	9.49	9.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	201.9	201.9	201.21	200.24	191.26	190.55
Additional Paid-in Capital	3.55	3.4	29.56	29.53	28.4	21.91
Accumulated Other Comprehensive Income	-0.11	-0.11	-0.16	-0.04	-	0.03
Retained Earnings	-170.25	-169.38	-187.43	-176.73	-163.65	-129.34
Shareholders' Equity	35.1	35.81	43.18	53.01	56.01	83.15
Total Liabilities & Equity	43.62	45.74	53.73	63.94	65.5	92.36

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.02	0.2	0.39	2.3	0.63	0.22
Net Cash (Debt)	9.85	10.61	11.3	15.69	23.51	33.89
Net Cash Growth	18.39%	-6.17%	-27.95%	-33.29%	-30.63%	2834.55%
Net Cash Per Share	0.02	0.03	0.03	0.04	0.09	0.14
Book Value	35.1	35.81	43.18	53.01	56.01	83.15
Book Value Per Share	0.08	0.09	0.11	0.15	0.20	0.33
Tangible Book Value	34.47	35.14	42.33	51.97	55.97	83.1
Tangible Book Value Per Share	0.08	0.08	0.10	0.14	0.20	0.33

Data Source: Fiscal.ai Last updated: May 13, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error